Top Story

Balloon capsules, swallowed then inflated, produce weight loss in nearly 65%

May 24, 2016

SAN DIEGO — Nearly 65% of participants who swallowed three capsules then filled with gas lost 5% or more of their total body weight, according to a presentation at Digestive Disease Week 2016.

“Individuals in the Obalon balloon treatment group also saw improvement in systolic blood pressure, fasting glucose, LDL cholesterol and triglycerides — outcomes that were not observed in the control group,” Shelby Sullivan, MD, director of bariatric endoscopy at Washington University School of Medicine in St. Louis, Mo., said during a press conference.

In the Journals

Flame-retardant exposure increases thyroid disease risk in women

May 24, 2016
High blood levels of polybrominated diphenyl ethers, or PBDEs, a common type of flame retardant, may increase the risk for thyroid problems in women, with the effect…
In the Journals

Microvascular disease increases risk for CV events in type 2 diabetes

May 24, 2016
In adults with type 2 diabetes free of cardiovascular disease, the burden of microvascular disease confers a risk for future cardiovascular events similar to the risks…
Business of Endocrinology

Barking up the wrong tree: More on drug pricing

Endocrine Today, May 2016
Richard O. Dolinar, MD
A bill currently before the Massachusetts Senate, S.1048, would require pharmaceutical companies to release information about the cost of the development and production…
Imaging Analysis

Incidental finding leads to parathyroid adenoma discovery

Endocrine Today, May 2016
Poorani Goundan, MBBS; Stephanie L. Lee, MD PhD ECNU
A 52-year-old woman with type 2 diabetes and hypertension was found to have hypercalcemia incidentally on routine blood testing. She did not have family history of…
More News Headlines »
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Meeting News Coverage

VIDEO: Late diagnosis of Cushing's disease still a problem

April 8, 2016
More »
Highlights from ENDO 2016

Highlights from ENDO 2016


New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues